Encoded Therapeutics
South San Francisco
About Encoded Therapeutics
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $239.1M
- Funding stage: Late Stage Venture
- Last round: Series D (Mar 2021)
- Website: encoded.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/encoded-therapeutics-36852 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.